| Healthy older patients see benefits from statin use |
| How infection affects the health of acute ischemic stroke patients |
| STEMI care in the wake of COVID-19: 3 research teams share their findings |
| Canadian cardiologist who was a childhood war hero dies at 89 |
| Preterm births associated with increased risk of ischemic heart disease for the mother |
| New polymer heart valve could be a breakthrough for valve replacement surgery |
| Revascularization vs. therapy alone for stable ischemic heart disease: What data from 15K patients tell us |
| AHA condemns Trump administration’s latest attack on ACA |
| Statin use leads to lower death rates among COVID-19 patients |
| What cardiologists should know about MIPS participation and COVID-19 |
| When demand outpaces supply: 4 key facts about the looming physician shortage |
| How telemedicine could change the lives of stroke survivors |
| USPSTF reaffirms recommendation for hypertension screening among adults |
| Imaging provider gains FDA clearance, CE mark approval for AI-powered right ventricle assessments |
| Injuries common during TEE-guided structural heart interventions—providers urged to weigh options |
| Outcomes continue to be favorable for low-risk TAVR patients receiving self-expanding valve |
| Sapien 3 TAVR outcomes comparable to surgery after 5 years |
| ‘Uniform, actionable information’: ACC, SVS to launch new vascular disease registry |
| A fresh look at what does (age, diabetes) and does not (hypertension) predict death from COVID-19 |
| Catheter-based heart failure treatment gains breakthrough device designation |
| TAVR-related bleeding complications plummet with protamine administration |
| Cardiologists shed new light on COVID-19 and cardiac arrhythmias |
| Protein boosts heart attack recovery, could be a game-changer for patients |
| FDA approves new fast-acting insulin for type 1 and type 2 diabetes |
| Diversity remains a big problem in cardiology—here’s how educators can help |
| Infective endocarditis after TAVR: 4 key findings from a new study of 7,000 patients |
| Specialists share experience prescribing a historically expensive cardiovascular medication |
| The top 10 hospitals for pediatric cardiology care |
| Lung ultrasound before PCI improves in-hospital management of STEMI patients |
| Treating type 2 diabetes with ertugliflozin does not increase risk of major cardiovascular events |
| Azithromycin associated with greater risk of cardiovascular death, but not sudden cardiac death |
| Dexamethasone improves outcomes for critically ill COVID-19 patients |
| Even mild myocardial injuries are a bad sign for COVID-19 patients |
| Update: FDA names 5 companies recalling extended-release metformin |
| Cardiologist makes history, performs first cardioneural ablation in US |
| Spectacular science: 3D model offers breathtaking look at what happens during a heart attack |
| Patient dies at home after doctors miss evidence of heart defect, including 2 chest x-rays |
| Gene-editing specialists raise $63M to combat coronary heart disease |
| Cardiology’s revenue down 57% in March, 73% in April |
| New payment model could save rural hospitals from a post-COVID collapse |
| Honoring the nearly 600 US healthcare workers who have died from COVID-19 |
| Patient access to TAVR centers: 3 key takeaways from a new study |
| AI algorithm predicts glucose levels one hour into the future |
| When experience is critical: High-volume operators associated with better left main PCI outcomes |
| Racial, gender disparities among heart transplant recipients with COVID-19 |
| ‘An important validation’: CMS issues new codes for IVL procedures |
| How telehealth affected cardiovascular care during the pandemic’s peak |
| Hypertension associated with greater risk of dying from COVID-19—but RAAS inhibitors can help |
| Hospital allegedly lied about COVID-19 patient’s death |
| American College of Cardiology launches new series of COVID-19-related virtual meetings |
| How a single question improves the effectiveness of CAC scanning |
| How one specialty hospital has kept COVID-19 at bay |
| Abiomed gains FDA approval to launch first-in-human trial for ‘world’s smallest heart pump’ |
| Indoor air filters associated with a significant decrease in systolic blood pressure |
| Welldoc receives additional FDA approval for digital diabetes solution |
| FFR-guided PCI earns high marks as a treatment option for patients with stable angina pectoris |
| Healthcare groups encourage black women to monitor, manage their blood pressure |
| Cardiologist sets sights on improving TAVR outcomes |
| Conscious sedation associated with better TAVR outcomes than general anesthesia |
| International Society of Hypertension updates global treatment guidelines |
| Modifying saturated fat intake helps decrease risk of cardiovascular events by 21% |
| What new research tells us about catheter ablation and atrial fibrillation |
| Society of Thoracic Surgeons condemns racism and violence as protests intensify |
| Cardiologists urge heart disease patients to seek emergency care when necessary |
| FDA approves use of ticagrelor for high-risk CAD patients |
| Hydroxychloroquine, chloroquine prescriptions skyrocketed in early stages of COVID-19 pandemic |
| For high-risk AF patients, NOACs outperform warfarin |
| In wake of George Floyd’s death, cardiovascular groups denounce ‘incidents of racism and violence’ |
| FDA approves emergency use of Abiomed’s Impella RP heart pump for certain COVID-19 patients |
| How health literacy can impact heart failure patients |
